Skip to content
Current Liabilities

Supplier Finance Program Obligations

Boston Scientific Supplier Finance Program Obligations increased by 0.7% to $145M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $129M to $145M. Over 3 years (FY 2022 to FY 2025), Supplier Finance Program Obligations shows an upward trend with a 3.7% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026
Metric ID: supplier_finance_obligations

Historical Data

13 periods
 Q4 '22Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$129M$124M$148M$152M$140M$131M$137M$140M$129M$139M$151M$144M$145M
QoQ Change-3.9%+19.4%+2.7%-7.9%-6.4%+4.6%+2.2%-7.9%+7.8%+8.6%-4.6%+0.7%
YoY Change+17.8%+5.6%-7.4%-7.9%-7.9%+6.1%+10.2%+2.9%+12.4%
Range$124M$152M
CAGR+4.0%
Avg YoY Growth+3.5%
Median YoY Growth+5.6%

Supplier Finance Program Obligations at Other Companies

Frequently Asked Questions

What is Boston Scientific's supplier finance program obligations?
Boston Scientific (BSX) reported supplier finance program obligations of $145M in Q1 2026.
How has Boston Scientific's supplier finance program obligations changed year-over-year?
Boston Scientific's supplier finance program obligations increased by 12.4% year-over-year, from $129M to $145M.
What is the long-term trend for Boston Scientific's supplier finance program obligations?
Over 3 years (2022 to 2025), Boston Scientific's supplier finance program obligations has grown at a 3.7% compound annual growth rate (CAGR), from $129M to $144M.